Authors : El Safadi M; School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.; Department of Chemistry, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.

Subjects: Deferiprone*/Deferiprone*/Deferiprone*/pharmacology ; Deferiprone*/Deferiprone*/Deferiprone*/chemistry ; Iron Chelating Agents*/Iron Chelating Agents*/Iron Chelating Agents*/pharmacology

Source: Molecules (Basel, Switzerland) [Molecules] 2024 Sep 05; Vol. 29 (17). Date of Electronic Publication: 2024 Sep 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read Online Read More Add to Saved list

Academic Journal

Conservative iron chelation for VAC14: Two-year clinical-radiological follow-up.

Authors : Ollivier T; Neurology and Movement Disorders Department, Expert Center for Parkinson's Disease, Lille University Hospital, Lille, France.; Univ. Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France Email: .

Subjects: Iron Chelating Agents*/Iron Chelating Agents*/Iron Chelating Agents*/therapeutic use ; Neuroaxonal Dystrophies*/Neuroaxonal Dystrophies*/Neuroaxonal Dystrophies*/drug therapy ; Neuroaxonal Dystrophies*/Neuroaxonal Dystrophies*/Neuroaxonal Dystrophies*/genetics Neuroferritinopathy

Source: Journal of Parkinson's disease [J Parkinsons Dis] 2025 Jun; Vol. 15 (4), pp. 925-928. Date of Electronic Publication: 2025 Apr 13.Publisher: SAGE Publications Country of Publication: United States NLM ID: 101567362 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Tumoroid Model Reveals Synergistic Impairment of Metabolism by Iron Chelators and Temozolomide in Chemo-Resistant Patient-derived Glioblastoma Cells.

Authors : Amereh M; Laboratory for Innovations in Micro Engineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC, V8P 5C2, Canada.; Seyfoori A

Subjects: Temozolomide*/Temozolomide*/Temozolomide*/pharmacology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism

Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 May; Vol. 12 (20), pp. e2412505. Date of Electronic Publication: 2025 Apr 26.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read Online Read More Add to Saved list

Academic Journal

Targeted active surveillance of branded generic deferasirox in pediatric thalassemia patients in a tertiary care hospital of India: A pharmacovigilance study.

Authors : Panigrahi M; Department of Pharmacology, AIIMS, Gorakhpur, Uttar Pradesh, India.; Swain TR

Subjects: Deferasirox*/Deferasirox*/Deferasirox*/adverse effects ; Deferasirox*/Deferasirox*/Deferasirox*/therapeutic use ; Iron Chelating Agents*/Iron Chelating Agents*/Iron Chelating Agents*/adverse effects

Source: Indian journal of pharmacology [Indian J Pharmacol] 2025 Mar 01; Vol. 57 (2), pp. 77-82. Date of Electronic Publication: 2025 Jun 13.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Iron chelators loaded on myocardiocyte mitochondria-targeted nanozyme system for treating myocardial ischemia-reperfusion injury in mouse models.

Authors : Zhu K; State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.; Wang K

Subjects: Myocardial Reperfusion Injury*/Myocardial Reperfusion Injury*/Myocardial Reperfusion Injury*/drug therapy ; Myocardial Reperfusion Injury*/Myocardial Reperfusion Injury*/Myocardial Reperfusion Injury*/metabolism ; Iron Chelating Agents*/Iron Chelating Agents*/Iron Chelating Agents*/pharmacology

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2025 Feb 15; Vol. 23 (1), pp. 112. Date of Electronic Publication: 2025 Feb 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

Read Online Read More Add to Saved list

Academic Journal

Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.

Authors : Devos D; Rascol O ...

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Deferiprone*/Deferiprone*/Deferiprone*/administration & dosage ; Deferiprone*/Deferiprone*/Deferiprone*/pharmacology

Source: Journal of Parkinson's disease [J Parkinsons Dis] 2025 Feb; Vol. 15 (1), pp. 72-86. Date of Electronic Publication: 2024 Dec 27.Publisher: SAGE Publications Country of Publication: United States NLM ID: 101567362 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Structural determination of mugineic acid, an iron(III)-chelating substance secreted from graminaceous plants for efficient iron uptake.

Authors : Kobayashi T; Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Nonoichi, Ishikawa, Japan.; K Nishizawa N

Subjects: Iron*/Iron*/Iron*/metabolism ; Azetidinecarboxylic Acid*/Azetidinecarboxylic Acid*/Azetidinecarboxylic Acid*/analogs & derivatives ; Azetidinecarboxylic Acid*/Azetidinecarboxylic Acid*/Azetidinecarboxylic Acid*/chemistry

Source: Proceedings of the Japan Academy. Series B, Physical and biological sciences [Proc Jpn Acad Ser B Phys Biol Sci] 2025; Vol. 101 (2), pp. 55-67.Publisher: Japan Academy Country of Publication: Japan NLM ID: 9318162 Publication Model: Print Cited Medium: Internet ISSN: 1349-2896

Record details

Streptomyces sp. from desert soil as a biofactory for antioxidants with radical scavenging and iron chelating potential.

Authors : Shah I; Department of Pharmacy, Comsats University Islamabad, Abbottabad Campus, Islamabad, Pakistan.; Uddin Z

Subjects: Streptomyces*/Streptomyces*/Streptomyces*/chemistry ; Streptomyces*/Streptomyces*/Streptomyces*/metabolism ; Soil Microbiology*

Source: BMC microbiology [BMC Microbiol] 2024 Oct 21; Vol. 24 (1), pp. 419. Date of Electronic Publication: 2024 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180

Record details

Read Online Read More Add to Saved list

Academic Journal

Iron Metabolism in Aminolevulinic Acid-Photodynamic Therapy with Iron Chelators from the Thiosemicarbazone Group.

Authors : Gawecki R; Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1A, 41-500 Chorzow, Poland.; SPIN-Lab Centre for Microscopic Research of Matter, University of Silesia in Katowice, 75 Pułku Piechoty 1A, 41-500 Chorzow, Poland.

Subjects: Aminolevulinic Acid*/Aminolevulinic Acid*/Aminolevulinic Acid*/pharmacology ; Aminolevulinic Acid*/Aminolevulinic Acid*/Aminolevulinic Acid*/chemistry ; Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods

Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 28; Vol. 25 (19). Date of Electronic Publication: 2024 Sep 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list

Academic Journal

Macrophage-derived extracellular vesicles represent a promising endogenous iron-chelating therapy for iron overload and cardiac injury in myocardial infarction.

Authors : Guo D; Department of Cardiology, Tangdu Hospital, Airforce Medical University, Xi'an, 710032, China.; Yang X

Subjects: Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/metabolism ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism ; Iron Overload*/Iron Overload*/Iron Overload*/metabolism

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Aug 31; Vol. 22 (1), pp. 527. Date of Electronic Publication: 2024 Aug 31.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Amphetamine-like Deferiprone and Clioquinol Derivatives as Iron Chelating Agents.

Conservative iron chelation for VAC14: Two-year clinical-radiological follow-up.

Tumoroid Model Reveals Synergistic Impairment of Metabolism by Iron Chelators and Temozolomide in Chemo-Resistant Patient-derived Glioblastoma Cells.

Targeted active surveillance of branded generic deferasirox in pediatric thalassemia patients in a tertiary care hospital of India: A pharmacovigilance study.

Iron chelators loaded on myocardiocyte mitochondria-targeted nanozyme system for treating myocardial ischemia-reperfusion injury in mouse models.

Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.

Structural determination of mugineic acid, an iron(III)-chelating substance secreted from graminaceous plants for efficient iron uptake.

Streptomyces sp. from desert soil as a biofactory for antioxidants with radical scavenging and iron chelating potential.

Iron Metabolism in Aminolevulinic Acid-Photodynamic Therapy with Iron Chelators from the Thiosemicarbazone Group.

Macrophage-derived extracellular vesicles represent a promising endogenous iron-chelating therapy for iron overload and cardiac injury in myocardial infarction.

Contact

Follow us